This page lists feature articles on COVID-19 relevant to people working at St Vincent's Health Australia.
All articles listed are open access unless stated otherwise.
Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial.
BMJ:2021:375:e068060 Full text
Associations of disease-modifying therapies with COVID-19 severity in multiple sclerosis.
Neurology:2021: October 5 Full text
Patient delay prior to care-seeking in acute myocardial infarction during the outbreak of the coronavirus SARS-CoV2 pandemic.
European Journal of Cardiovascular Nursing:2021: October 29 Full text
Maintaining high standards of clinical research during the Covid-19 pandemic: insights from an excellence clinical research centre.
European Heart Journal:2021:42(41):4202-25 Full text
Safe traveling in public transport amid COVID-19.
Science Advances:2021: October 22 Full text
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2.
Journal of Clinical Virology:2021: November 4 Full text
Neurological complications in COVID-19 patients with ECMO support: a systematic review and meta-analysis.
Heart, Lung and Circulation:2021:2021: October 28 Full text
Increased complications of COVID-19 in people with cardiovascular disease: role of the renin–angiotensin-aldosterone system (RAAS) dysregulation.
Chemico-Biological Interactions:2021: November 3 Full text
Effects of covid-19 pandemic on life expectancy and premature mortality in 2020: time series analysis in 37 countries.
BMJ:2021:375:e066768 Full text
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months.
New England Journal of Medicine:2021: November 4 Full text
Waning of SARS-CoV-2 antibodies targeting the Spike protein in individuals post second dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and risk of breakthrough infections: analysis of the Virus Watch community cohort.
MedRxiv:2021: November 9 Full text
Antibody titers before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in adults aged ≥60 years.
JAMA:2021: November 5 Full text
Association between mRNA vaccination and COVID-19 hospitalization and disease severity.
JAMA:2021: November 4 Full text
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), August-September 2021, the Netherlands.
MedRxiv:2021: October 14 Full text
Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age.
New England Journal of Medicine:2021: November 9 Full text
SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a wide variety of tissues.
Cell Reports:2021: November 3 Full text
Emotional correlates of the COVID-19 pandemic in individuals with and without diabetes.
Diabetes Care:2021: November 5 Full text
Changes in the prevalence of symptoms of depression, loneliness, and insomnia in U.S. older adults with type 2 diabetes during the COVID-19 pandemic: the Look AHEAD Study.
Diabetes Care:2021: November 9 Full text